Why Drug Companies Can't Tell The FDA About Every Research Project

Why Drug Companies Can't Tell The FDA About Every Research Project

Should the FDA have been involved in “Project Protect”? First of all, it must be pointed out that every biopharma R&D organization seeks a “back-up” or second generation compound for any promising medicine in its pipeline. Given the risky nature of

4
Like
Save

Comments

Write a comment

*